TABLE 2.
Composite outcome | Total number of patients |
Events n (%) |
30‐day absolute risk, % (95% CI) † | Standardized average risk ratio (95% CI) |
---|---|---|---|---|
No psychiatric disorders ‡ | 127,281 | 1551 (1.2) | 1.3 (1.2–1.4) | Ref. |
Schizophrenia spectrum disorders | 984 | 48 (4.9) | 3.1 (2.3–3.9) | 2.43 (1.79–3.07) |
Bipolar disorder | 485 | 20 (4.1) | 2.7 (1.6–3.8) | 2.11 (1.25–2.97) |
Unipolar depression | 3764 | 102 (2.7) | 2.2 (1.7–2.6) | 1.70 (1.38–2.02) |
Other psychiatric disorders | 7328 | 73 (1.0) | 1.4 (1.1–1.8) | 1.13 (0.86–1.38) |
Psychotropic drug redemption § | 4479 | 242 (5.4) | 2.1 (1.9–2.4) | 1.70 (1.48–1.92) |
COVID‐19, coronavirus disease 2019; CI, confidence interval.
Cox models included age, sex, highest obtained education, income, ischaemic heart disease, congestive heart failure, cerebrovascular disease, chronic kidney disease, hypertension, peripheral artery disease, diabetes, chronic obstructive pulmonary disorder, asthma, substance abuse and malignancy.
Patients without prior psychiatric diagnoses and who did not redeem psychotropic drugs within 90 days prior to index date.
Within 90 days prior to index date without having a hospital psychiatric diagnosis.